Plain-English translation of NCT06378905 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Doctors treating advanced ovarian cancer need to decide quickly whether patients should have surgery immediately or receive chemotherapy first. This study is validating a tool called the Cukurova Score—developed at one hospital—to see if it works reliably across many different hospitals. The score uses imaging and a small exploratory procedure to predict which patients will have the best surgical outcomes.
Right now, decisions about surgery timing for advanced ovarian cancer often depend on each surgeon's experience and judgment. This validation study will test whether the Cukurova Score can be used consistently across different hospitals to make these critical decisions more fair and evidence-based.
You likely qualify if…
You likely don't qualify if…
You will likely provide access to your medical records, imaging scans, and surgical information so researchers can assess how well the Cukurova Score predicts your surgical outcomes. The study is observational, meaning you will not receive a new treatment—instead, your existing medical information will be reviewed and analyzed across 20 hospitals in Turkey to validate the scoring tool.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Turkey (Türkiye)
Muğla Sıtkı Koçman University, Sakarya University
Enrollment target
~130 participants
Started
May 2024
Primary completion
March 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 100 Years
Sex
Female only
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ghanim Khatib, MD
Cukurova University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.